Physician
Elias H Kassab MD PLLC
Elias H Kassab MD PLLC was paid $3.90M by Medicaid between Jan 2018 and Dec 2024, across 53 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 21% of everything it billed.
33Billing provider infoELIAS H KASSAB MD PLLC
DEARBORN, MI 48126
DEARBORN, MI 48126
33aNPI1437585106assigned 09/25/2013
33bProvider typeCardiovascular Disease Physician
28Total paid$3.90M
24GClaims87,423
24DCodes billed53
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Cardiovascular Disease Physician providers in Michigan
Rank by total paid#7 of 134
Median peer was paid$91K
This provider vs. median43×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,729 | $278K | |
| 2019 | 7,771 | $303K | |
| 2020 | 11,253 | $428K | |
| 2021 | 16,471 | $658K | |
| 2022 | 19,291 | $700K | |
| 2023 | 16,857 | $888K | |
| 2024incomplete | 9,051 | $644K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 12,231 | 11,278 | $836K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 11% | 4,540 | 4,514 | $432K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 11% | 6,634 | 2,071 | $416K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 9.8% | 2,107 | 2,049 | $383K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 8.4% | 2,090 | 2,029 | $327K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.8% | 2,807 | 2,798 | $266K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.0% | 5,338 | 4,985 | $235K |
| J2785 | Injection, regadenoson, 0.1 mg | 5.6% | 1,562 | 1,505 | $219K |
| 99223 | Prolong inpt eval add15 m | 5.4% | 2,006 | 1,920 | $211K |
| 93458 | 3.2% | 829 | 819 | $124K | |
| 93970 | 2.2% | 799 | 795 | $87K | |
| 93015 | 1.7% | 2,289 | 2,228 | $66K |
41 more codes
| 93000 | 1.6% | 7,348 | $62K | |
| 93979 | 1.4% | 807 | $55K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 740 | $31K |
| 93880 | <1% | 242 | $27K | |
| 93923 | <1% | 709 | $18K | |
| 93925 | <1% | 119 | $16K | |
| 93351 | <1% | 116 | $16K | |
| 99457 | <1% | 441 | $13K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,107 | $10K |
| 99454 | <1% | 264 | $9K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 112 | $7K |
| 93244 | <1% | 440 | $6K | |
| 93227 | <1% | 333 | $4K | |
| 93225 | <1% | 335 | $4K | |
| 93298 | <1% | 161 | $3K | |
| 93242 | <1% | 441 | $3K | |
| 93971 | <1% | 38 | $3K | |
| 93978 | <1% | 24 | $3K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 143 | $3K |
| 99221 | <1% | 28 | $2K | |
| 99220 | <1% | 12 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 39 | $824.60 |
| 99406 | <1% | 67 | $539.05 | |
| J0280 | Injection, aminophyllin, up to 250 mg | <1% | 53 | $326.41 |
| 93922 | <1% | 13 | $178.26 | |
| 99156 | <1% | 15 | $177.48 | |
| 99453 | <1% | 12 | $137.34 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 37 | $22.85 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 3,794 | $0.82 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | <1% | 1,609 | $0.15 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 10,295 | $0.10 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 4,181 | $0.02 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 3,896 | $0.01 |
| 1036F | 0% | 2,203 | $0.00 | |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 560 | $0.00 |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 409 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 30 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 930 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 897 | $0.00 |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 140 | $0.00 |
| 4004F | 0% | 51 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKASSAB, ELIAS (OWNER/PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Ehk Endovascular PLLC | Dearborn, MI | $151K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.